2010 Scrip 100 - A sense of venture
This article was originally published in Scrip
Executive Summary
Corporate venture funds are taking an increasingly high-profile role in biotech financing deals. Eva Jack and Dr Maggie Flanagan LeFlore, managing directors of MedImmune Ventures, explain to Pete Chan why their drivers are both financial and strategic.